Purchase Order 75D30120P09648
- Not listed
- This is a federal purchase order award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the delivery of ONT MinION sequencing kits. The $21,577 firm-fixed-price contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, with a period of performance ending on September 29, 2024. No set-aside was used for this award. Oxford Nanopore Technologies is a prime contractor for this purchase order and...
- This is a $41,180 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the acquisition of MinION MK1C basic starter packs on behalf of the CDC's operations in Thailand. Oxford Nanopore Technologies is a provider of nanopore-based electronic systems for DNA, RNA, and protein analysis, and has secured numerous prime federal contracts from...
- This is a $48,400.00 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the delivery of laboratory supplies, with no set-aside designation. Oxford Nanopore Technologies Inc. has secured numerous prime federal contracts and subcontracts with agencies like the NIH, USDA, and DOD, primarily for the provision of next-generation genomic sequencing...
- Oxford Nanopore Technologies Inc. received a $95,605 firm fixed-price purchase order (Contract #GRD-CAPEX) from a civilian Southeast Area federal agency for genomic sequencing equipment and services, with performance in Cambridge, Massachusetts. The contract was awarded on September 5, 2019, with an ultimate completion date of October 4, 2019. This award was not associated with a small business set-aside designation. Oxford Nanopore Technologies Inc., a foreign-owned biotechnology firm...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order contract to Oxford Nanopore Technologies Inc. to provide genomic sequencing equipment, consumables, and services. The $16,300.00 contract, which has no set-aside designation, was awarded on July 9, 2019 with a completion date of May 15, 2023. Oxford Nanopore Technologies Inc. is a foreign-owned, for-profit organization that develops nanopore-based electronic...
- The Department of Health and Human Services Centers for Disease Control and Prevention has awarded a firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit company, to provide a GridION Mk1 capex sequencing system and associated lab equipment and supplies. The $126,680 contract has a completion date of December 13, 2022 and does not utilize a set-aside designation. Based on previous federal contract awards, Oxford Nanopore Technologies Inc. provides...
- This is a $95,755 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the acquisition of GridION MK1 CAPEX equipment. The award has no set-aside designation. Oxford Nanopore Technologies Inc. has received multiple prime federal contract awards from agencies such as the NIH, USDA, and DOD to provide next-generation genomic sequencing platforms, consumables,...
- This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, is for the provision of sequencing technology and associated services to support research initiatives. The $20,210 firm fixed price purchase order, awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh, does not have a set-aside designation. Oxford Nanopore Technologies holds additional federal contract vehicles, including a $300,000 blanket purchase...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $140,950 firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for the GRIDION MK1 CAPEX. The contract, which does not have a set-aside designation, is for the delivery of Oxford Nanopore's nanopore sequencing devices, flow cells, reagents, kits, software, and related services and support. The contract will be performed in Lexington,...
- The U.S. government awarded a Purchase Order contract valued at $4,999.00 to Oxford Nanopore Technologies Inc., a biotechnology company specializing in nanopore-based sequencing systems, on February 28, 2017, with completion targeted for March 10, 2017. The contract, titled "Enhanced Minion Starter Pack (2189)," was issued through the Plains Area civilian agency and does not include a set-aside designation. Work will be performed in Cambridge, Massachusetts. Oxford Nanopore...
This firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit organization, to provide MINION-2 SEQUENCERS. The contract has a ceiling value of $38,062 and a completion date of October 9, 2020. Oxford Nanopore Technologies Inc. is a biotechnology company that develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins. The company has secured numerous prime federal contract awards from agencies like the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and U.S. Department of Defense (DOD) to provide next-generation genomic sequencing equipment, consumables, and associated services. This contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($311) | 7/10/24 | |
| Not listed | Not listed | $38.2k | 8/28/20 |